Navigation Links
CalbaTech, Inc. Officially Changes Name to LifeStem International, Inc.; Lists New Symbol (LSTM) and Launches New Web Site
Date:5/1/2008

LAGUNA HILLS, Calif., May 1 /PRNewswire-FirstCall/ -- LifeStem International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, Inc. (OTC Bulletin Board: CLBE), the emerging life sciences company concentrating on the collection and banking of adult stem cells for possible future therapeutic uses, today announced that as of May 2, it will have officially changed its name, obtained a new trading symbol, effected a 3000 for 1 reverse stock split, and launched its new website at http://www.lifesteminternational.com.

The new web site gives significant background on the Company's proprietary Stem Cell MicroBank(TM), its unique method of stem cell banking that allows healthy individuals to collect and store their stem cells for possible future therapeutic use. The web site also explains the Company's Research Reagents Division, which includes K-D Medical, Inc. and MoleculA, Inc. in Columbia, Maryland. Also included on the site is information for the investor on our financial filings and news releases, as well as information on management and the scientific advisory board.

LifeStem's Stem Cell MicroBank(TM) Service is a process that involves the harvesting of adult stem cells in micro quantities from both blood and adipose tissue. The cells are then cryopreserved for future possible therapeutic applications and therapies, such as grafting new skin cells for burn victims, regenerating corneas and producing and regulating insulin for diabetics.

About LifeStem International, Inc.

LifeStem International, Inc. (OTC Bulletin Board: LSTM) is the emerging life sciences company (http://www.lifesteminternational.com), concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells.

Note: Certain statements in this news release may contain "forward-looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to being in a large and growing market, exhibiting rapid growth characteristics, and having a growth strategy, are forward-looking statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or assumptions in this press release include the risk that we will not be able to grow our revenues and market share, the risk that our prices do not remain competitive and the risk that we will not achieve profitability. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Contact: Paul Knopick

E & E Communications

949/707-5365

pknopick@eandecommunications.com


'/>"/>
SOURCE LifeStem International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Albertsons Officially Launches Healthy Eaters(TM) Field Trip Program
3. University Hospital of Bordeaux Officially Opens New Electrophysiology Lab
4. Hooray for the Bay! San Francisco Officially Named Best Place to Leave Your Heart...and Keep Your Health
5. Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company
6. CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville
7. Genetic Changes May Dictate Course of Acute Myeloid Leukemia
8. GSK Announces Changes to Corporate Executive Team
9. Changes to Family and Medical Leave Act Clarify Employer Responsibilities
10. Procter & Gamble Announces Board Changes
11. Physicians Anticipate Changes in Their Usage of Hip Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently ... balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive ...
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of ... a lot to offer to the discussion of dealing with excess skin oil. “Oily skin ... many home remedies that can help remove the oily shine while keeping the skin fresh ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... with or without a referral. Sleep apnea is often left untreated because patients are ... headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep ...
(Date:3/27/2017)... Philadelphia PA and London UK (PRWEB) , ... ... ... have the speed, agility and ability to gain site attention and engagement over ... DrugDev educational webinar will discuss how partnering with the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN DIEGO and VANCOUVER, British Columbia, March 27, ... SPHS ) (the "Company" or "Sophiris"), a clinical ... treatment of patients with urological diseases, today reported ... and key corporate highlights. Key ... in Clinical Development for Localized Prostate Cancer. During ...
(Date:3/27/2017)... , March 27, 2017 /PRNewswire/ - INVICTUS MD ... IVITF; FRA: 8IS) Invictus MD is pleased to announce ... shares for trading on the TSX Venture Exchange.  ... TSXV follows a year of significant achievements for Invictus-MD. ... successful test crops at AB Laboratories Inc. ("AB Labs"), ...
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
Breaking Medicine Technology: